FDA Approved: GEMFIBROZIL — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for Gemfibrozil from Zydus Lifesciences Limited. This approval updates the existing ANDA for Gemfibrozil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)